ImmunOs
6 known investors
Find your way into ImmunOs
Immunos Therapeutics develops therapies for immuno-oncology and inflammatory diseases. The company focuses on advancing treatments in cancer immunotherapy and inflammation-related conditions.
Investors · 6
Competitors · 4
by search overlapImmune-Onc Therapeutics28 shared keywordsImmune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.
Immunomic Therapeutics23 shared keywordsImmunomic Therapeutics develops nucleic acid immunotherapy platforms, particularly self-amplifying RNA and plasmid DNA vaccines, for cancer treatment, allergies, and animal health applications. The company's UNITE® platform leverages lysosomal targeting technology to generate immune responses against CMV, HPV, and other tumor-associated antigens across multiple cancer types and allergic conditions.
Syneos Health19 shared keywordsSyneos Health is a fully integrated biopharmaceutical solutions organization that provides clinical, medical affairs, and commercial services to help pharmaceutical companies accelerate market access and patient outcomes.
Immunai14 shared keywordsImmunai develops AMICA, a data platform for decoding the immune system to accelerate drug discovery and development. The company serves pharmaceutical and biotech researchers working on inflammatory and oncological therapies.
Companies competing with ImmunOs for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does ImmunOs do?
- Immunos Therapeutics develops therapies for immuno-oncology and inflammatory diseases. The company focuses on advancing treatments in cancer immunotherapy and inflammation-related conditions.
- Who are ImmunOs's investors?
- ImmunOs's investors include BioMedPartners, Lightspeed Venture Partners, Mission Biocapital, Pfizer Venture Investments, Pfizer Ventures, redalpine.